Table 2.
Prevalence of hypertension and antihypertensive drug class type used according to frailty status (n = 619)
| Robust (n = 201) | Prefrail (n = 324) | Frail (n = 94) | Pvalue a | |
|---|---|---|---|---|
| Hypertension | ||||
| Yes | 104 (51.7) | 235 (72.5) | 78 (83.0) | < .001b |
| No | 97 (48.3) | 89 (27.5) | 16 (17.0) | |
| Antihypertensive treatment | ||||
| β‐Blocker | ||||
| Yes | 36 (17.9) | 111 (34.3) | 41 (43.6) | < .001b |
| No | 165 (82.1) | 213 (65.7) | 53 (56.4) | |
| ARB | ||||
| Yes | 51 (25.4) | 80 (24.7) | 38 (40.4) | < .001b |
| No | 150 (74.6) | 244 (75.3) | 56 (59.6) | |
| ACEI | ||||
| Yes | 65 (23.9) | 93 (23.9) | 21 (22.3) | .824 |
| No | 163 (76.1) | 297 (76.1) | 73 (77.7) | |
| CCB | ||||
| Yes | 12 (6.0) | 35 (10.8) | 12 (12.8) | .11 |
| No | 189 (94.0) | 289 (89.2) | 82 (87.2) | |
| Diuretics | ||||
| Yes | 38 (18.9) | 124 (38.3) | 49 (47.9) | < .001b |
| No | 163 (81.1) | 200 (61.7) | 45 (52.1) | |
| Others | ||||
| Yes | 7 (3.5) | 29 (9.0) | 5 (5.3) | .042c |
| No | 194 (96.5) | 295 (91.0) | 89 (94.7) | |
Values are expressed as number (percentage).
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.
a
Chi‐square test with Monte Carlo correction. Pairwise differences (test using Bonferroni corrections).
b
Found between all groups except frail vs prefrail.
c
Found only in robust vs prefrail.